Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonia Netzl

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
STAR Protocols|January 18, 2024
Protocol to isolate nuclei from Chlamydomonas reinhardtii for ATAC sequencingIndu Santhanagopalan, Antonia Netzl, Tanya Mathur, et al.
Scientific Reports|October 24, 2025
Combining antigenic data from public sources gives an early indication of the immune escape of emerging virus variantsAntonia Netzl, Sina Türeli, Eric B LeGresley, et al.
Journal of Leukocyte Biology|June 19, 2019
Diminished secretion and function of IL-29 is associated with impaired IFN-α response of neonatal plasmacytoid dendritic cellsLukas Wisgrill, Isabelle Wessely, Antonia Netzl, et al.
The Journal of Infectious Diseases|November 28, 2023
Durability of Cross-Neutralizing Antibodies 5.5 Months After Bivalent Coronavirus Disease 2019 Vaccine BoosterAnnika Rössler, Ludwig Knabl, Antonia Netzl, et al.
Cell Reports|January 4, 2025
Nonhuman primate antigenic cartography of SARS-CoV-2Annika Rössler, Antonia Netzl, Ninaad Lasrado, et al.
Nature Communications|August 26, 2023
Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartographyAnnika Rössler, Antonia Netzl, Ludwig Knabl, et al.
Nature Communications|December 13, 2022
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variantsAnnika Rössler, Antonia Netzl, Ludwig Knabl, et al.
NPJ Vaccines|May 18, 2024
Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster seraAnnika Rössler, Antonia Netzl, Ludwig Knabl, et al.
NPJ Vaccines|July 1, 2026
Mapping SARS-CoV-2 immunity after an XBB.1.5 booster by antigenic cartography of merged human and hamster seraMarta Bermejo-Jambrina, Antonia Netzl, Ludwig Knabl, et al.
Vaccine|July 5, 2025
Exposure to two antigenically distinct SARS-CoV-2 variants broadens neutralization patternsMelanie M Schmitt, Annika Rössler, Antonia Netzl, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
STAR Protocols|January 18, 2024
Protocol to isolate nuclei from Chlamydomonas reinhardtii for ATAC sequencingIndu Santhanagopalan, Antonia Netzl, Tanya Mathur, et al.
Scientific Reports|October 24, 2025
Combining antigenic data from public sources gives an early indication of the immune escape of emerging virus variantsAntonia Netzl, Sina Türeli, Eric B LeGresley, et al.
Journal of Leukocyte Biology|June 19, 2019
Diminished secretion and function of IL-29 is associated with impaired IFN-α response of neonatal plasmacytoid dendritic cellsLukas Wisgrill, Isabelle Wessely, Antonia Netzl, et al.
The Journal of Infectious Diseases|November 28, 2023
Durability of Cross-Neutralizing Antibodies 5.5 Months After Bivalent Coronavirus Disease 2019 Vaccine BoosterAnnika Rössler, Ludwig Knabl, Antonia Netzl, et al.
Cell Reports|January 4, 2025
Nonhuman primate antigenic cartography of SARS-CoV-2Annika Rössler, Antonia Netzl, Ninaad Lasrado, et al.
Nature Communications|August 26, 2023
Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartographyAnnika Rössler, Antonia Netzl, Ludwig Knabl, et al.
Nature Communications|December 13, 2022
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variantsAnnika Rössler, Antonia Netzl, Ludwig Knabl, et al.
NPJ Vaccines|May 18, 2024
Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster seraAnnika Rössler, Antonia Netzl, Ludwig Knabl, et al.
NPJ Vaccines|July 1, 2026
Mapping SARS-CoV-2 immunity after an XBB.1.5 booster by antigenic cartography of merged human and hamster seraMarta Bermejo-Jambrina, Antonia Netzl, Ludwig Knabl, et al.
Vaccine|July 5, 2025
Exposure to two antigenically distinct SARS-CoV-2 variants broadens neutralization patternsMelanie M Schmitt, Annika Rössler, Antonia Netzl, et al.
Pageof 3